Skip to content
Medical Health Aged Care, National News Current Affairs

Steps4migraine ‘stepping up’ awareness and research for five million who endure Australia’s leading cause of disability

Steps4migraine 3 mins read


Migraines are the number one cause of disability in Australia. Now the country’s peak bodies are banding together to form Steps4migraine in a hope to bring about change.


Coinciding with World Migraine Day on Sunday 18 June, Steps4migraine will see a procession of 1,150 Victorians walking from Parliament Gardens to Victoria Square (opposite Queen Victoria Market), clocking up 5 million steps to symbolise the number of Aussies who suffer this debilitating neurological disease.


Senior neurologist, Migraine Foundation Australia Chair and migraine sufferer, Professor Tissa Wijeratne, said the facts around migraine are startling and require urgent action.


“Much of the community is oblivious to the huge physical, social and economic toll of migraine. This morning, more than 250,000 Australians are experiencing migraine pain, rendering them unable to function properly,” he said.


“This crippling condition costs the nation more than $40 billion a year which takes into account the costs to the health system plus lost productivity, yet there’s a distinct lack of empathy and urgency in stopping the physical, emotional, social and economic impact of the condition.


“Our national medical research funder, the National Health and Medical Research Council (NHMRC) which falls under the Department of Health, allocates very little money towards migraine research. In fact, between 2007 and 2017, the Council directed only 0.09% of its total budget to migraine research.


“As well as affecting one-in-four Aussie households, we know that migraine is strongly linked to mental health issues, with international research finding that depression affects almost 80% of migraine sufferers at one time or another.


“There is currently no cure for migraine­ – only means of managing symptoms and reducing frequency which can make sufferers feel helpless and hopeless – so more funding for research is desperately needed to ‘crack the code’.”


Steps4migraine participants are raising money through a 5 million step challenge and there’s still time to get involved via #Steps4migraine and The funds raised will go towards education, service delivery and research in this field. Providing access for patients hindered by location or finances is also a key priority.


Professor Wijeratne says migraine continues to be the most neglected, worst managed and least respected medical disorder.


“Community engagement and raising awareness is the key to changing this, which is where the Steps4migraine campaign can make a huge difference along with more adequate government funding and focus.


“There is very little teaching on this topic in our medical schools and neurology specialist training programs. We desperately need research, education and better support to end this misery forever.


“Providing patients with appropriate, evidence-based care would dramatically move the needle on the global burden of migraine. There is a need for improved standards of care so that all can access safe treatment regardless of financial situation, gender, culture or location.”



WHAT:            Steps4migraine advocacy and fundraising walk – clocking up 5 million steps representing the 5 million Aussies who suffer migraine

WHEN:            Sunday 18 June         

11.30am ahead of the walk’s commencement at 12 midday

WHERE:         Parliament Gardens, Corner of Spring and Albert Street, Melbourne – the starting point for the walk

WHO:              Senior neurologist and Migraine Foundation Australia Chair Professor Tissa Wijeratne

                        Chronic migraine sufferers Mrs Stav Sasso and Mrs Kate Kenfield


To find out more about the event or migraines visit:

Key Facts:

Quick facts

·       The number one cause of disability in Australia is migraine.

·       $40 billion – cost of migraine to Australia per year.

·       Five million Australians suffer from migraine.

·       1 billion people worldwide suffer from migraine.

·       Migraine is more than just a headache it’s a chronic neurological disease.

About us:

About migraines – more than just a headache


Migraine is a disabling neurological disease. This complex brain disorder is not just a headache. Migraine has five phases from prodrome, aura, acute attack phase, postdrome and interictal phase. Its cause is genetic – triggers, lifestyle and environmental factors play a role too.


Chronic migraine can last for months to years at times. Professor Tissa Wijeratne has seen patients who’ve had no headache-free days for well over 30 years.


Acute attack of migraine is characterised by severe head pain, cognitive impairment, nausea, vomiting, dizziness, vertigo, and sensitivity to light, sound and touch. It is also highly associated with long COVID, stroke, heart disease, epilepsy, depression, and chronic pain. Early diagnosis and access to effective treatment are vital to helping patients find relief and improve their quality of life.

Contact details:


Chriss Mannix, Soda Communications, 0418 408 035,

Karen Strahan, Soda Communications, 0417 361 465,

More from this category

  • Medical Health Aged Care, Science
  • 17/07/2024
  • 14:00
De Motu Cordis

De Motu Cordis (DMC) announces plans for the next stage of development for DMC-IH1, an inhaled epinephrine drug device combination product

Brisbane, QLD – 17 July 2024 – De Motu Cordis (DMC) today announced plans for the next stage of development with its Contract Development and Manufacturing Organization (CDMO) partner, Catalent, at Catalent’s Boston, Morrisville and San Diego sites. These expansion plans encompass services from drug product manufacturing and device assembly through to commercial launch of DMC’s product, DMC-IH1. DMC-IH1 is an inhaled epinephrine drug-device combination product being developed for the treatment of anaphylaxis using a dry powder inhaler (DPI). Catalent DPI drug delivery services offer end-to-end solutions to bring customers through the entire clinical pharma journey by leveraging the commercial…

  • Medical Health Aged Care, Women
  • 17/07/2024
  • 07:00
Monash University

Study underlines the importance of supporting primary care clinicians to deliver early medical abortion and long acting reversible contraception

The impetus for additional support and training for clinicians wanting to deliver important sexual and reproductive services has received a boost with the release of Monash University-led research. Published in BMJ – Sexual and Reproductive Health, the AusCAPPS study found that GPs, nurses and pharmacists seek peer support and online resources to deliver long-acting reversible contraception (LARC) and early medical abortion (EMA) in Australian primary care.Experienced and emerging providers of LARC and EMA sought support regarding clinical issues online from AusCAPPS, which is the Australian Contraception and Abortion Primary Care Practitioner Support Network, an evidence-based virtual community of practice launched…

  • Medical Health Aged Care
  • 17/07/2024
  • 03:11
Interrad Medical, Inc.

Interrad Medical’s SecurAcath is Superior to Standard of Care in Newly Published Randomized Controlled Clinical Study

PLYMOUTH, Minn.–BUSINESS WIRE– Interrad Medical, Inc., a privately held medical device company, announces excellent results of a clinical study published in JAMA Pediatrics titled,…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.